Ground Floor, Adamson House, Towers Business Park, Wilmslow Road, Didsbury, M20 2YY

+44(0)161 546 8800

Research Delivery Model

Our integrated research care model gives patients the support they need, through a joined approach across local councils, the NHS, and life science companies. It removes traditional divisions between hospitals and family doctors, between physical and mental health, and between NHS and council services.

In the past, these divisions have meant that too many people experienced disjointed care. Our knowledge highlights the barriers holding back the development of effective clinical care and access to new treatments. Understanding these barriers gives us insight to the best ways to improve innovation in health care systems.

Our expert delivery teams create centres of excellence across primary and secondary sectors, implementing integrated research opportunities, high functioning and performing oncology services to improve patient outcomes and experience. Our integrated research care model reduces costs and improves management efficacy and productivity as we help healthcare providers rethink their strategies, identify, and seize opportunities, eliminate surplus and variability, optimise resources and improve practice.

Global Better Health Programme

A £79.3 million partnership providing strategic and technical expertise to the Global Better Health Programme (BHP) hosted by Health Education England (HEE).

The aim of this programme is to strengthen local health system by redesigning operating models and structures to improve quality of care.

Integrated Research Care

Over the last decade, an average of 28% of EU clinical trial applications have come from the UK. This is only a fraction of the potential market opportunity open to the UK.

Working as an oncology network we increase efficiencies across time, reliability, governance and cost with expanding our portfolio of research clinical sites.

Systemic Anti-Cancer Therapy (SACT) Research

The patient need for systemic anti-cancer therapy (SACT) which are the drug treatments, increase roughly 10-15% per year and improve survival for cancer patients.

Breast cancer (BC) leads the way but other cancers follow the same trend.